[en] PROBLEM: The human tumor-associated receptor-binding cancer antigen expressed on SiSo cells (RCAS1) is considered to play a role in the inhibition of the maternal immune response during pregnancy. The aim of our study was to investigate the expression of RCAS1 protein in the placenta and to compare its concentration in maternal and cord blood sera between normal pregnancies and pregnancies complicated by gestational diabetes mellitus (GDM). METHOD OF STUDY: Samples were obtained from women with GDM (n = 8), women with type 1 DM (n = 5), and healthy term controls (n = 27) after delivery. Placentas were studied by immunohistochemistry, and real-time polymerase chain reaction. For assessment of RCAS1 concentrations in maternal and cord blood sera, enzyme-linked immunosorbent assay was performed. RESULTS: The RCAS1 protein mRNA expression in the placentas of patients with GDM was significantly lower than that in the controls (P = 0.005). The maternal blood RCAS1 protein concentration of the GDM cases was also significantly lower than that in the controls (P = 0.0411), whereas the cord blood RCAS1 protein concentration was significantly higher in the GDM and type 1 DM groups than in the controls (P = 0.0311 and P = 0.0192, respectively). CONCLUSION: The present results suggest that RCAS1 protein might have an important role in the development of GDM.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Tskitishvili, Ekaterine ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement > Osaka University Graduate School of Medicine, Department of Obstetrics and Gynecology
Komoto, Yoshiko; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Kinugasa, Yukiko; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Kanagawa, Takeshi; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Song, Mihyon; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Mimura, Kazuya; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Tomimatsu, Takuji; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Kimura, Tadashi; Osaka University Graduate School of Medicine > Department of Obstetrics and Gynecology
Shimoya, Koichiro; Kawasaki School of Medicine > Department of Obstetrics and Gynecology
Language :
English
Title :
Relationship between human tumor-associated antigen RCAS1 and gestational diabetes mellitus.
Gabbe S: Gestational diabetes mellitus. N Engl J Med 1986; 315: 1025-1026.
Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S: Gestational diabetes induces placental genes for chronic and inflammatory pathways. Diabetes 2003; 52: 2951-2958.
Wolf M, Sauk J, Shah A, Smirnakis KV, Jimenez-Kimble R, Ecker JL, Thadhani R: Inflammation and glucose intolerance:a prospective study of gestational diabetes mellitus. Diabetes Care 2004; 27: 21-27.
Sargent IL, Borzychowski AM, Redman C: NK cells and human pregnancy-an inflammatory view. Trends Immunol 2006; 27: 399-404.
Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med 1999; 5: 938-942.
Reimer TA, Anagnostopoulos I, Erdmann B, Lehmann I, Stein H, Daniel P, Dorken B, Rehm A: Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker. BMC Cancer 2005; 5: 47.
Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T: A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 1996; 77: 1501-1509.
Ikeda K, Sato M, Tsutsumi O, Tsuchiya F, Tsuneizumi M, Emi M, Imoto I, Inazawa J, Muramatsu M, Inoue S: Promoter analysis and chromosomal mapping of human EBAG9gene. Biochem Biophys Res Commun 2000; 273: 654-660.
Matsushima M, Nakashima M, Oshima K, Abe Y, Nishimura J, Nawata H, Watanabe T, Muta K: Receptor binding cancer antigen expressed on SiSo cells,a novel regulator of apoptosis of erythroid progenitor cells. Blood 2001; 98: 313-321.
Akahira JI, Aoki M, Suzuki T, Moriya T, Niikura H, Ito K, Okamura K, Inoue S, Sasano H, Yaegashi N: Expression of EBAG9/RCAS1 is associated with advanced disease in human epithelial ovarian cancer. Br J Cancer 2004; 90: 2197-2202.
Chatterjee M, Mohapatra S, Ionan A, Bawa G, Ali-Fehmi R, Wang X, Novak J, Ye B, Nahhas FE, Lu K, Witkin SS, Fishman D, Munkarah A, Morris R, Levin NK, Shirley NN, Tromp G, Abrams J, Draghici S, Tainsky MA: Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arrays. Cancer Res 2006; 66: 1181-1190.
Sonoda K, Miyamoto S, Yotsumoto F, Yagi H, Nakashima M, Watanabe K, Nakano H: Clinical significance of RCAS1 as a biomarker of ovarian cancer. Oncol Rep 2007; 17: 623-628.
Wicherek L, Klimek M, Dutsch-Wicherek M, Kolodziejski L, Skotniczny K: The molecular changes during placental detachment. Eur J Obstet Gynecol Reprod Biol 2006; 125: 171-175.
Kawano K, Kaku T, Sonoda K, Hirakawa T, Kobayashi H, Ohishi Y, Nakano H: Expression of RCAS1 in female organs. Int Gynecol Pathol 2005; 24: 330-334.
Wicherek L, Popiela TJ, Galazka K, Dutch-Wicherek M, Oplawski M, Basta A, Klimek M: Metallothionein and RCAS1 expression in comparison to immunological cells activity in endometriosis, endometrial adenocarcinoma and endometrium according to menstrual cycle changes. Gynecol Oncol 2005a; 99: 622-630.
Wicherek L, Dutsch M, Mak P, Klimek M, Skladzien J, Dubin A: Comparative analysis of RCAS1 level in neoplasms and placenta. Acta Biochim Pol 2003; 50: 1187-1194.
Ohshima K, Nakashima M, Sonoda K, Kikuchi M, Watanabe T: Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy:tHe possible role in immune privilege. Clin Exp Immunol 2001; 123: 481-486.
Wicherek L, Dutsch-Wicherek M, Mak P, Klimek M: The role of RCAS1 and oxytocinase in immune tolerance during pregnancy. Fetal Diagn Ther 2005b; 20: 420-425.
Wicherek L, Klimek M, Dutsch-Wicherek M: The level of maternal immune tolerance and fetal maturity. Neuro Endocrinol Lett 2005c; 26: 561-566.
Wicherek L, Klimek M, Czekierdowski A, Popiela TJ, Galazka K, Tetlak T, Gilowski A, Dutsch-Wicherek M: The placental RCAS1 expression during stillbirth. Reprod Biol Endocrinol 2005d; 3: 24.
Tskitishvili E, Komoto Y, Kinugasa Y, Kanagawa T, Song M, Mimura K, Tomimatsu T, Kimura T, Shimoya K: The human tumor-associated antigenRCAS1 in pregnancies complicated by pre-eclampsia. J Reprod Immunol 2007; doi: 10.1016/j.jri2007.05.01.
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
Ategbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, Miled A, Grissa A, Jerbi M, Takba Z, Khan NA: Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006; 91: 4137-4143.
Lapolla A, Betterle C, Sanzari M, Zanchetta R, Pfeifer E, Busianro A, Fagiolo U, Plebani M, Marini S, Photiou E, Fedele D: An immunological and genetic study of patients with gestational diabetes mellitus. Acta Diabetol 1996; 33: 139-144.
Rodacki M, Milech A, De Oliveira JE: NK cells and type 1 diabetes. NK cells and type 1 diabetes. Clin Dev Immunol 2006; 13: 101-107.
Rodacki M, Svoren B, Butty V, Besse W, Laffel L, Benoist C, Mathis D: Altered natural killer cells in type 1 diabetec patients. Diabetes 2007; 56: 177-185.
Lapolla A, Sanzari M, Marini S, Floriani F, Piva I, Erle G, Fedele D: A study on lymphocyte subpopulations in diabetic pregnant women and their newborn. Ann Ist Super Sanita 1997; 33: 429-432.
Lapolla A, Sanzari M, Zancanaro F, Masin M, Guerriero G, Piva I, Toniato R, Erle G, Plebani M, Fedele D: A study on lymphocyte subpopulation in diabetic mothers at delivery and in their newborn. Daibete Nutr Metab 1999; 12: 394-399.
